The Journal of Allergy and Clinical Immunology
Volume 121, Issue 6 , Pages 1460-1466.e7, June 2008

Children with egg allergy have evidence of reduced neonatal CD4+CD25+CD127lo/− regulatory T cell function

  • Miranda Smith, BSc

      Affiliations

    • School of Paediatrics and Child Health, University of Western Australia, Perth, Australia
  • ,
  • Michelle R. Tourigny, BSc, PhD

      Affiliations

    • Telethon Institute for Child Health Research, Perth, Australia
  • ,
  • Paul Noakes, BSc, PhD

      Affiliations

    • School of Paediatrics and Child Health, University of Western Australia, Perth, Australia
  • ,
  • Catherine A. Thornton, BSc, PhD

      Affiliations

    • Institute of Life Science, School of Medicine, Swansea University, Swansea, United Kingdom
  • ,
  • Meri K. Tulic, BSc, PhD

      Affiliations

    • School of Paediatrics and Child Health, University of Western Australia, Perth, Australia
  • ,
  • Susan L. Prescott, MD, PhD

      Affiliations

    • School of Paediatrics and Child Health, University of Western Australia, Perth, Australia
    • Corresponding Author InformationReprint requests: Susan L. Prescott, MD, PhD, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, PO Box D184, Princess Margaret Hospital, Perth WA 6001, Australia.

Received 28 October 2007; received in revised form 27 March 2008; accepted 27 March 2008. published online 06 May 2008.

Background

The role of regulatory T (Treg) cells in allergic predisposition is not known.

Objective

This study compared the frequency and function of cord blood Treg cells from nonallergic children (n = 18) with those from children who have egg allergy (n = 15) in the first year of life.

Methods

CD4+ effector T cells and autologous antigen-presenting cells isolated from cord blood mononuclear cells were cocultured with or without CD4+CD25+CD127lo/− Treg cells, and cytokine responses to staphylococcal endotoxin B were assessed after 48 hours.

Results

The addition of Treg cell populations to cord blood mononuclear cell cultures resulted in significant reduction in IL-10 (P = .002), IL-13 (P = .012), and IFN-γ (P < .001) production. Consistent with other reports, effector CD4+ T-cell responses (IFN-γ and IL-13) tended to be lower in the allergic group. These neonates showed less significant Treg cell–associated suppression of IFN-γ (P = .015) compared with that seen in the nonallergic group (P = .001). The allergic group was also less likely (44%) to show Treg cell–associated suppression of IFN-γ effector responses compared with that seen in the nonallergic group (78%, P = .015). The magnitude of suppression (change in IFN-γ level when CD4+CD25+CD127lo/− Treg cells were added to responding effector T-cell cultures) was significantly lower in the allergic group (P = .004). There were no between-group differences in the circulating CD4+CD25+CD127lo/− Treg cells (as a percentage of cord blood T cells) or in the FOXP3 expression of these cells.

Conclusion

This study confirms the presence and activity of Treg cells in cord blood and provides preliminary evidence of differences in neonates who progress to allergic disease in the first year of life.

Key words: Regulatory T cells, cord blood, neonates, food allergy, allergic disease, egg allergy, cytokines, infants

Abbreviations used: CBMC, Cord blood mononuclear cell, HDM, House dust mite, OVA, Ovalbumin, SEB, Staphylococcal endotoxin B, SPT, Skin prick test, Treg, Regulatory T

 

 S.L.P. is funded by the National Health and Medical Research Council (NHMRC) of Australia. The project used the flow cytometry facility, which was funded by a Centre of Excellence grant from the Western Australian government and is located at the Telethon Institute for Child Health Research.

 Disclosure of potential conflict of interest: The authors have declared that they have received research support from the National Health and Medical Research Council of Australia.

PII: S0091-6749(08)00609-X

doi:10.1016/j.jaci.2008.03.025

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 6 , Pages 1460-1466.e7, June 2008